CT Scanner Market

The CT Scanner market is projected to expand from US$ 7.01 billion in 2024 to US$ 10.10 billion by 2031, with an estimated CAGR of 5.35% from 2025 to 2031.

Analyst's Perspective

The analysis of the CT Scanner market identifies key growth factors, including the rising incidence of chronic diseases, an increasing need for early diagnosis, and advancements in healthcare infrastructure. Additionally, innovations in CT scanner technology are expected to create new market trends from 2022 to 2030.

A computerized tomography (CT) scanner is a medical imaging device that utilizes X-rays from various angles to produce detailed images of the body's bones, blood vessels, and soft tissues, offering more detail than standard X-rays. CT scanners are commonly employed to assess individuals who may have sustained internal injuries from car accidents or other traumas. This imaging technique can visualize nearly all body parts, aiding in the diagnosis of injuries or diseases. Furthermore, it is utilized in planning medical, surgical, or radiation treatments for affected areas during disease diagnosis.

Market Overview

Rising Incidence of Chronic Diseases to Drive CT Scanner Market

According to a report by the National Institute of Biomedical Imaging and Bioengineering published in June 2022, CT has become a reliable screening tool for identifying potential cancers or lesions in the abdomen. A heart CT scan may be advised when various cardiac conditions or abnormalities are suspected. CT scans of the head can also help detect injuries, tumors, clots that may lead to strokes, bleeding, and other conditions. They can assess the lungs for cancers, pulmonary embolisms (blood clots), excess fluid, and other diseases such as emphysema or pneumonia. CT scans are particularly useful for identifying complex bone fractures, severely damaged joints, or bone cancers due to their superior detail compared to traditional X-rays. Consequently, the increasing prevalence of chronic conditions like cardiovascular diseases, cancer, neurological disorders, and orthopedic issues has led to a significant patient population undergoing computed tomography scans globally. The National Center for Health Statistics reported 1,898,160 new cancer cases in the US in 2021, highlighting the growing demand for computed tomography scanners. Additionally, a report from Harvard Health in September 2021 indicated that approximately 90.0 million CT scan procedures are conducted annually in the US.

Leading companies are launching advanced technological products to gain a competitive advantage. For example, in April 2021, Hitachi, Ltd. introduced the newly designed Scenaria 64-slice CT scanner, aimed at reducing radiation exposure, enhancing efficiency, and supporting interventionists in their practices. This product launch is part of Hitachi's strategy to strengthen its product offerings in a competitive market.

Strategic Insights

Emerging Trends

Technological Innovations in CT Scanners as a Future Trend

With growing concerns regarding radiation exposure, there has been a significant emphasis on dose-reduction technologies in CT scanners. This includes advancements in iterative reconstruction techniques, automatic exposure control, and other dose optimization methods to lower radiation doses while preserving image quality. The American Cancer Society recommends annual screening with a low-dose CT (LDCT) scan for adults aged 50 and older who smoke or have a history of smoking to detect lung cancer.

A study published by Science Direct in 2022 examined the relationship between incidental findings related to respiratory diseases from the National Lung Screening Trial (NLST) and respiratory disease mortality (RDM), excluding lung cancer detected during LDCT screenings. The study involved 26,722 participants in the NLST LDCT arm, with 25,002 undergoing both baseline and follow-up LDCT screenings. It found that incidental findings such as emphysema and reticular opacities were associated with higher RDM.

Various strategies implemented by key players are propelling market growth. For instance, in December 2023, Fujifilm India partnered with Soorya Diagnostics LLP to place its latest CT scan equipment at Soorya Diagnostics Center, promoting a culture of screening and enhancing access to quality healthcare services in the region.

Report Segmentation and Scope

The "CT scanner market" is categorized based on type, architecture, technology, application, end user, and geography. The market is divided into stationary and portable CT scanners based on type. In terms of architecture, the CT scanner market is split into C-arm CT Scanners and O-arm CT Scanners. By technology, the market is segmented into high slice CT, midsize CT, low slice CT, and cone beam CT. The application-based segmentation includes oncology, neurology, orthopedics, and other applications. For end users, the market is classified into hospitals, diagnostic centers, research laboratories, and veterinary clinics. Geographically, the CT scanner market is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Type-Based InsightsThe CT scanner market is divided into stationary and portable CT scanners. The stationary CT scanners segment held a larger market share in 2022 and is expected to exhibit the highest CAGR from 2022 to 2030.

Architecture-Based Insights

The CT scanner market is categorized by architecture into C-arm CT Scanners and O-arm CT Scanners, with the C-arm CT Scanners segment leading the market in 2022.

Technology-Based Insights

The CT scanner market is segmented by technology into high slice CT, midsize CT, low slice CT, and cone beam CT, with the high slice CT segment holding the largest market share in 2022.

Application-Based Insights

The CT scanner market is segmented by application into oncology, neurology, orthopedics, and other applications, with the neurology applications segment holding the largest market share in 2022.

End User-Based Insights

The CT scanner market is categorized by end users into hospitals, diagnostic centers, research laboratories, and veterinary clinics. The hospital segment held the largest market share in 2022 and is projected to register the highest CAGR from 2022 to 2030.

CT Scanner Market Report Scope Regional Analysis

North America is anticipated to achieve the highest CAGR in the global CT scanner market from 2022 to 2030. North America held the largest market share in 2022 and is expected to maintain its leading position throughout the forecast period. The North American market is segmented into the US, Canada, and Mexico, with the US holding the largest share due to the rising prevalence of inflammatory diseases, the presence of major industry players, advancements in the healthcare sector, the introduction of innovative CT scan systems, and technological progress in CT scans in the region.

Key players in the global CT scanner market include GE Healthcare, Siemens Healthcare Private Limited, Koninklijke Philips N.V., TOSHIBA IT and CONTROL SYSTEMS CORPORATION, HTSI Healthcare Solutions, Shimadzu Corporation, SAMSUNGHEALTHCARE.COM, Neusoft Corporation, Medtronic, and Shenzhen Anke High-Tech Co., Ltd. These leading companies are focused on expanding and diversifying their market presence and clientele, which is expected to positively impact the CT scanner market.

Some notable developments by major market players include:

In November 2022, FUJIFILM launched the SCENARIA View Focus Edition, a premium CT scanner in the US, featuring Cardio StillShot, an advanced Cardiac Motion Correction technology that provides 6x higher temporal resolution than traditional image reconstruction methods. This device is suitable for both routine and advanced clinical applications and was introduced at RSNA 2022.

In April 2022, Wipro GE Healthcare launched its advanced Revolution Aspire CT scanner, designed and manufactured entirely in India at the Wipro GE Medical Devices Manufacturing plant, offering enhanced imaging intelligence for more accurate clinical diagnoses.In November 2021, Siemens Healthineers launched Naeotom Alpha, the first photon-counting CT scanner approved for clinical use in the USA and Europe, which offers significant improvements, including enhanced resolution and a reduction in radiation dose by up to 45% for ultra-high-resolution scans compared to conventional CT detectors.